|
| |
| | Chronic Hepatitis C: Current Disease Management |
 | | In view of the rapid developments in hepatitis C today, better therapies may become available within the next few years, at which point expanded indications for therapy would be appropriate. | | | Viral levels as measured by HCV RNA do not correlate with the severity of the hepatitis or with a poor prognosis (as in HIV infection); but viral load does correlate with the likelihood of a response to antiviral therapy. | | | At present, the only means of preventing new cases of hepatitis C are to screen the blood supply, encourage health professionals to take precautions when handling blood and body fluids, and inform people about high-risk behaviors. |
|
http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc
|
|
| |
| | Hepatitis C |
| | HCV is vertically transmitted from mother to infant, and the risk of transmission is correlated with the titer of HCV RNA in the mother. | | | Quantitative HCV RNA test and genotyping should be performed if therapy is considered. | | | Histological findings changed the decision to initiate HCV therapy in 19 patients (17%) because of little or no fibrosis. |
|
http://www.thedoctorsdoctor.com/diseases/hepatitis_C.htm
|
|
| |
| | Hepatitis Information Network: HepNet - Hepatitis C |
| | Topics include ''Evolution of Therapy for Chronic Hepatitis C'' by Eugene R. Schiff, MD, ''Interferon/Ribavirin Combination Therapy in Treatment-Naïve Patients'' by John G. McHutchison, MD, ''Interferon/Ribavirin Combination Therapy in Relapsers'' by Ira M. Jacobson, MD, ''Cost-Effectiveness of Treatment for Hepatitis C'' by John B. Wong, MD, ''Putting Theory Into Practice'' by Willis C. Maddrey, MD. | | | February 4, 2000: Interferon therapy reduces the risk for hepatocellular carcinoma: Dr. Howard Worman reviews a recent paper examining a national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. | | | Topics include ''Hepatitis C: Dilemmas in Treatment'' by: Mitchell Shiffman, MD, ''Identifying the Sustained Responder'' by: David Gretch, MD, ''Pharmacoeconomic and Ethical Concerns in Managing the Disease'' by: Raymond Koff, MD, and ''Update on Treatment Options'' by: Donald Jensen, MD. |
|
http://www.hepnet.com/hepc.html
|
|
| |
| | Hepatitis C |
| | Most new infections are associated with high-risk drug behaviors. | | | This occurs at the time of birth, and there is no treatment that can prevent it from happening. | | | These persons need to be identified, tested, and counseled. |
|
http://www.astdhpphe.org/infect/hepc.html
|
|
| |
| | Hepatitis C - Alternative Treatment for Hepatitis Alchemist Lab |
| | Non-toxic Hepatitis C Therapy originally came out in July of 2001 and we have gained valuable new medicines to overcome HepC since that point. | | | Products contains our shopping cart and descriptions of medicines, how they affect liver health and why they are useful in chronic hepatitis. | | | In Blood Tests and Signs/Symptoms we differentiate the treatment of HCV infection; this is not one size fits all, but rather a choreographed response from years of treating hepatitis clinically. |
|
http://www.alchemistlab.com
|
|
| |
| | Hepatitis C |
| | The natural history of chronic HCV infection can vary dramatically between individuals. | | | Such individuals should be considered for possible participation in clinical studies. | | | Most patients with chronic hepatitis C will be asymptomatic or have non-specific symptoms such as fatigue. |
|
http://cpmcnet.columbia.edu/dept/gi/hepC.html
|
|
| |
| | HCV |
| | The WHO program to improve injection practices by use of disposable non-reusable syringes and needles is valuable, but will likely take decades to reach all parts of the developing world, and in particular drug users. | | | Hepatitis C is particularly fatal in patients with HIV. | | | Among those who do experience effects of the disease, often take the form of flu-like symptoms, i.e., fatigue, muscle aches, and nausea. |
|
http://www.heprf.org/hcv.htm
|
|
| |
| | HCV |
| | Even when available, vaccines will not alleviate the problems faced by millions of chronic HCV carriers worldwide. | | | AS with HBV, chronic HCV infection is a major risk factor for HCC (30% of UK HCC patients?). | | | Read: Terrault, N.A. "Treatment of chronic hepatitis B and chronic hepatitis C" Rev.Med.Virol. |
|
http://www.tulane.edu/~dmsander/WWW/335/HCV.html
|
|
| |
| | BBC NEWS Health Medical notes Hepatitis C |
| | In this the skin turns yellowish, as do the whites of the eyes. | | | About 40% of patients respond to this "combination" therapy. | | | Although some modern treatments can control it in some patients, on the whole it remains an infection which is very hard to treat. |
|
http://news.bbc.co.uk/2/hi/health/medical_notes/695934.stm
|
|
| |
| | VA National Hepatitis C Program |
| | Veterans whose lives have been touched by hepatitis C explore the use of art as therapy. | | | Management of Psychiatric and Substance Use Disorders in Patients with Hepatitis C | | | Basic information on hepatitis C for patients, their families, and the general public |
|
http://www.hepatitis.va.gov
|
|
| |
| | Management of Hepatitis C: 2002 |
| | Chau TN, Lai ST, Lai JY, Yuen H. Acute viral hepatitis in Hong Kong: a study of recent incidences. | | | HCV infection in Egyptian patients with acute hepatitis. | | | Fulminant liver failure from acute HCV superinfection in a patient with HIV, HBV, and HDV coinfections. |
|
http://www.nlm.nih.gov/pubs/cbm/hepatitis_c_2002.html
|
|
| |
| | Hepatitis C |
| | Visit our online store for products related to this guide. | | | Exciting new treatments have recently been developed which can markedly improve the disease, and perhaps even cure, some people with Hepatitis C Virus. | | | A combination of interferon and ribavirin (Rebetol) has been shown to be quite effective in a number of recent studies. |
|
http://www.afraidtoask.com/STD/hcv.html
|
|
| |
| | Hepatitis C Virus |
| | Wong, MD, New England Medical Center, Tufts University School of Medicine, Boston. | | | Left untreated, hepatitis C can lead to chronic hepatitis, cirrhosis (scarring of the liver), liver cancer, and death. | | | Hepatitis C is the most common blood-borne infection in the United States. |
|
http://home.att.net/~vet_updates/vets-hep.htm
|
|
| |
| | Hepatitis C ... HCV treatments .. Save a life Beat Hepatitis C |
| | This site is also a great source for research and learning about: hepatitis c ( hcv), hepatitis c ( hep c) treatment, cancer therapy and alternative medicine treatment for hepatitis c. | | | The types of alternative medicine include milk thistle, natcell thymus, natcell liver and others as well, that will help you reduce the chance of liver disease. | | | Triumph Over Hepatitis C is a graphic depiction of how the American medical machine fails to deal with hep c - hcv, and it provides the alternative medicine solution that is reversing the hepatitis c virus in those who use it. |
|
http://hepatitiscfree.com
|
|
| |
| | Viral Hepatitis |
| | Hepatitis Case Studies from the Dept. Pathology and Laboratory Medicine, RWJMS. | | | It is likely that further hepatitis viruses will be described at some time in the future. | | | (N.B. There are many non-infectious causes of hepatitis, e.g. |
|
http://www.tulane.edu/~dmsander/WWW/335/Hepatitis.html
|
|
| |
| | HCV Advocate.org |
| | Click on "HCV Advocate" in the top left corner to return to home at any time. | | | Search this site from any page by using the search field at the top right. |
|
http://www.hcvadvocate.org
|
|
|
